Therapeutics

Since inception and driven by a passion for ocular medicine and treatments GreenLight Clinical has been focused on building extraordinary clinical, research and laboratory expertise in the field of ophthalmology.

Our significant experience and expertise in ophthalmology studies combined with our operational capability, compliance with global regulatory bodies ensures a flexible approach to the needs of our clients.  This coupled with our supported central laboratory capability and bench of researchers accelerates the path to approval. 

Driving outcomes through advanced therapy experience and a strategic approach to patient recruitment including pediatrics, geriatrics, and rare diseases ensure a comprehensive partnership combined with our CAP-accredited central lab services for safety testing, PK/PD, biomarkers and genomic testing.

Finally, we are supported by our executive leadership expert Associate Professor Andrew Chang, and CEO Dr Sasi Suda, we pride ourselves on developing deep partnerships with clients to develop potential drugs and devices involving all areas of the eye, from the ocular surface to the posterior segment of the eye, and all conditions affecting the organ, like presbyopia, macular degeneration, and retinitis pigmentosa, diabetic retinopathy, glaucoma, and dry eye syndrome.

Indication experience includes –

• Age-related macular degeneration / genetic macular degeneration
• Leber’s Congenital Amaurosis
• Retinitis Pigmentosa
• Achromatopsia
• Glaucoma
• Presbyopia
• Diabetic Macular Edema
• Devices

With a collective experience spanning over a century, our physicians and clinicians are highly adept with demonstrated experience across both hematology and oncology drug and bio-clinical development.

Our central lab capability with in house imaging services provide an integrated approach and seamless platform to deliver your study or trial with expertise and understanding of the most complex nuances.

Driving outcomes through advanced therapy experience and a strategic approach to patient recruitment including pediatrics, geriatrics, and rare diseases ensure a comprehensive partnership and expedited planning and execution of effective studies.  

Finally, we are supported by our executive leadership team and CEO Dr Sasi Suda.  We pride ourselves on developing deep partnerships with clients to develop potential drugs and devices.

Indication experience includes –

• Colorectal Cancer
• Pancreatic Cancer
• Solid Tumors – Basket Study
• Soft Tissue Sarcoma
• Breast Cancer
• Gastric Cancer
• Head and Neck Cancer
• Leukemia
• Cervical Cancer
• Lung Cancer
• Lymphoma
• Multiple Myeloma
• Oesophageal Cancer
• Ovarian Cancer
• Paediatric Cancer
• Brain Cancer
• Prostate Cancer
• Renal Cancer
• Skin Cancer

With a broad experience base across the business in designing and conducting global phase I-IV clinical trials in adult and paediatric populations, in both new and re-emerging infectious diseases, we are able to assist our client in achieving not only study goals and objectives but also in obtaining government and non-dilutive funding.

Our global Central Laboratory and Clinical Trial Logistics service ensure that we are able to manage and deliver valuable investigational products in difficult to access regions, ensure sample integrity and facilitate speciality testing, including both microbiology and virology to fully support your programs.

Driving successful achievement of trial outcomes via access to leading research scientists both in-house and in partnership, we pride ourselves on the delivery of high quality study reporting, regulatory interface and the ability to meet tight deadlines and go-to-market plans.

Our commitment to bringing new vaccines and treatments to market is backed by our executive leadership team and CEO Dr Sasi Suda. Dr .Suda’s special interest in providing new preventative therapies to the developing world is a key driver of our work in the field, and we pride ourselves on developing deep partnerships with our clients to bring new products to the patients who need them most.

GreenLight Clinical’s experience in the neurology/CNS space spans over 20 years, with our teams being involved in key clinical trials of novel therapies for CNS disorders across the globe.

Our patient-centric, innovative approaches to clinical trial design, investigator interaction and participant support ensure that the patient’s quality-of-life is our focus at all times, along with providing meaningful support to their caregivers every step of the way.

We are experienced in pediatric, young-adult, adult and geriatric populations, and the nuance that comes with different age groups and conditions in CNS trials.

Our Clinical Operations teams have an in-depth knowledge of screening tools and rating scales, and can provide oversight for rater services including subjective assessments, inter-rater reliability and scale validation.

Some of the areas we have experience in include –

• Epilepsy
• Ischaemic Stroke
• Migraine
• Multiple Sclerosis
• Subarachnoid Haemorrhage
• TTR amyloidosis
• Alzheimer’s Disease
• Wilson Disease
• Huntington Disease
• Acute Pain
• Neuropathic pain

GreenLight Clinical has extensive global experience in endocrine/metabolic trials in both developed and emerging markets, along with difficult-to-recruit populations.

Leading your trial are highly experienced experts with global trial management backgrounds and hands-on know-how, covering the full spectrum of endocrine and metabolic disorders including concomitant diseases (obesity, hypertension, and associated co-morbidities).

Our operational staff are supported by our Patient Recruitment and Retention team, specialized in the development and implementation of retention techniques including support and education coupled with specific strategies for site issues associated with diabetes and obesity trial management.

Our in-depth experience includes broad compound experiences such as Type 1 and Type 2 diabetes, major obesity programmes, hypercholesterolemia, mixed dyslipidemia and triglyceride.

Some of the areas we have experience in include –

• Type 2 Diabetes
• Lipid Studies
• Obesity Studies
• Rare Disease

GreenLight Clinical’s experience in rare diseases and orphan indications spans the globe, executing innovative trials in numerous countries, with the needs of the patient in focus at all times.

Given the difficulty of identifying patient populations, key opinion leaders and principal investigators in rare disease, GreenLight Clinical’s Medical Science Liaison team is at the core of our approach to these studies.

Fully embedded with the sponsor, a dedicated MSL team leverages your product knowledge and vision with best-in-class clinical trial intelligence and global medical information services to engage the most suitable sites and investigators to reach your target population.

Our in-house Biostatistics and Medical Writing teams are at the cutting-edge of trial design, developing innovative approaches to maximise statistical power and enrolment efficiency – ensuring rapid progress towards your goals.

These teams are supported by a strategic, physician-led approach with both pediatric and wider rare-disease experience to ensure the needs of the patient are considered at all times, and that programs can successfully interface with global regulatory requirements.

Some of the areas we have experience in include –

• Cushing’s Syndrome
• Dravet Syndrome
• Duchenne Muscular Dystrophy
• Fibrodysplasia
• Growth Hormone Deficiency
• Renal Vasculitis
• Retinitis Pigmentosa
• Stargardt Disease
• Retinoblastoma
• Coloboma
• Acromegaly

GreenLight Clinical’s experience in dermatology spans topical, transdermal, intravenous and injection based approaches in both the therapeutic and cosmetic space.

Our focus in the rapidly growing Asia-Pacific region gives you access to valuable new markets in dermatology, and our global footprint allows you to leverage your results into global opportunities.

With highly capable Clinical Operations teams, backed by our global Regulatory Affairs department, GreenLight Clinical is a trusted partner for product development in dermatology.

Some of the areas we have experience in include –

• Acne
• Rosacea
• Psoriasis
• Eczema
• Atopic Dermatitis
• Tinea Pedis and Fungal Conditions
• Impetigo
• Melanoma